PATENT CLAIM ANALYSIS

Application Number: 15771648
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["424", "204100"]

Abstract:
Safe, rapid and efficient methods for producing antigen-specific T cells recognizing human papilloma virus or HPV antigens.

Claim (Index 23):
A composition comprising:\n i. T cells and T cell precursor cells that have been separated from dendritic cells and dendritic precursor cells and that are naive to an HPV peptide antigen, ii. cytokines including but not limited to at least one of IL-2, IL-6, IL-7, IL-12, and IL-15, at various points in the culture period, and iii. a medium that maintains the viability of said T cells and T-cell precursor cells.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 91.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15885197', '15331659', '14364592', '10222960', '12271576']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7463238744599779
- 35 USC 102 Novelty (BERT): 0.5258176141369666
- Combined Prediction Score: 0.7242732484276768
- Mean Citation Score: 294.7064400000001
- Max Citation Score: 344.2144
- Similarity Product: 260.8725434547424

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test